BridgeBio Pharma, Inc. BBIO
CIK 0001743881
Form 4 transactions dated Sep 1, 2023 to Sep 26, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $0.00
- Sold
- $1.03B
Sep 1, 2023 – Aug 20, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2024-11-19 | Kumar Neil Chief Executive Officer · Director | Sale10b5-1 footnote | $613.83K 27,389 shares sold | 0.56% sold Direct holding | ▾ |
| 2024-11-19 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Sale10b5-1 footnote | $93.14K 4,156 shares sold | 4.24% sold Direct holding | ▾ |
| 2024-09-13 | KRAVIS HENRY R · ROBERTS GEORGE R · KKR & Co. Inc. · KKR Management LLP · KKR Group Partnership L.P. · KKR Group Holdings Corp. · KKR Genetic Disorder L.P. · KKR Genetic Disorder GP LLC · KKR Group Co. Inc. 10% owner | Sale | $149.35M 5,800,000 shares sold | Unavailable Indirect holding | ▾ |
| 2024-08-19 | Kumar Neil Chief Executive Officer · Director | Sale10b5-1 footnote | $676.26K 27,389 shares sold | Unavailable Direct holding | ▾ |
| 2024-08-19 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Sale10b5-1 footnote | $102.59K 4,155 shares sold | 4.65% sold Direct holding | ▾ |
| 2024-06-04 | Scott Randal W. Director | Sale10b5-1 footnote | $46.95K 1,500 shares sold | 27.27% sold LLC holding | ▾ |
| 2024-06-03 | Scott Randal W. Director | Sale10b5-1 footnote | $28.84K 1,000 shares sold | 15.38% sold LLC holding | ▾ |
| 2024-03-01 | Scott Randal W. Director | Sale10b5-1 footnote | $85.00K 2,500 shares sold | 27.78% sold LLC holding | ▾ |
| 2024-02-15 | Valantine Hannah Director | Sale10b5-1 footnote | $110.04K 2,915 shares sold | 62.30% sold Direct holding | ▾ |
| 2024-01-16 | Valantine Hannah Director | Sale10b5-1 footnote | $110.68K 2,915 shares sold | 62.30% sold Direct holding | ▾ |
Showing 10 / 10 record groups in 2024. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 10 of 10 purchase / sale groups and 30 of 86 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"BBIO","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.